We are live on ! Find out more
PCM

Pavaki Capital Management Portfolio holdings

AUM $287M
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$235M
AUM Growth
-$19.8M
Cap. Flow
+$10.3M
Cap. Flow %
4.36%
Top 10 Hldgs %
50.47%
Holding
162
New
31
Increased
16
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$13.2M
2
EWS icon
iShares MSCI Singapore ETF
EWS
+$1.69M
3
ESPR
Esperion Therapeutics
ESPR
+$1.3M
4
B
Barrick Mining
B
+$1.27M
5
NAMS icon
NewAmsterdam Pharma
NAMS
+$1.19M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.8M
2
SPRY icon
ARS Pharmaceuticals
SPRY
+$5.71M
3
OGN icon
Organon & Co
OGN
+$3.01M
4
ROIV icon
Roivant Sciences
ROIV
+$868K
5
ALT icon
Altimmune
ALT
+$778K

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.44%
2 Healthcare 20.32%
3 Materials 13.21%
4 Energy 8.84%
5 Technology 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AQST icon
76
Aquestive Therapeutics
AQST
$596M
$519K 0.22%
125,000
– –
ERIC icon
77
Ericsson
ERIC
$30.4B
$507K 0.22%
45,000
– –
VRT icon
78
CALL
Vertiv
VRT
$95.6B
$501K 0.21%
2,000
– –
IVZ icon
79
Invesco
IVZ
$13.4B
$486K 0.21%
20,000
– –
SPOT icon
80
CALL
Spotify
SPOT
$101B
$485K 0.21%
1,000
– –
TOL icon
81
Toll Brothers
TOL
$12.5B
$478K 0.2%
3,500
– –
CDE icon
82
Coeur Mining
CDE
$18.3B
$465K 0.2%
+24,795
New +$540K
SHW icon
83
CALL
Sherwin-Williams
SHW
$80.2B
$449K 0.19%
1,400
– –
STT icon
84
State Street
STT
$48.8B
$443K 0.19%
3,500
– –
PTEN icon
85
Patterson-UTI
PTEN
$4.02B
$433K 0.18%
+40,000
New +$342K
CHRD icon
86
Chord Energy
CHRD
$7.35B
$427K 0.18%
3,000
– –
CPS icon
87
Cooper-Standard Automotive
CPS
$377M
$418K 0.18%
15,000
– –
CTSH icon
88
Cognizant
CTSH
$25.6B
$417K 0.18%
+6,800
New +$487K
KYIV
89
Kyivstar Group
KYIV
$2.95B
$412K 0.17%
+40,692
New +$482K
SMCI icon
90
CALL
Super Micro Computer
SMCI
$26.9B
$410K 0.17%
18,000
– –
AEM icon
91
Agnico Eagle Mines
AEM
$94.1B
$406K 0.17%
2,000
– –
XLK icon
92
PUT
State Street Technology Select Sector SPDR ETF
XLK
$127B
$399K 0.17%
+3,000
New +$423K
AESI icon
93
Atlas Energy Solutions
AESI
$1.46B
$394K 0.17%
+30,000
New +$350K
SEIC icon
94
SEI Investments
SEIC
$12.4B
$392K 0.17%
5,000
– –
AU icon
95
AngloGold Ashanti
AU
$47.9B
$389K 0.17%
4,000
– –
RZLT icon
96
Rezolute
RZLT
$396M
$366K 0.16%
120,000
– –
IYW icon
97
PUT
iShares US Technology ETF
IYW
$26.4B
$363K 0.15%
2,000
– –
DYN icon
98
Dyne Therapeutics
DYN
$3.03B
$363K 0.15%
+20,000
New +$345K
ARKW icon
99
PUT
ARK Next Generation Technology ETF
ARKW
$1.93B
$362K 0.15%
3,000
– –
BNY
100
Bank of New York Mellon
BNY
$99.7B
$356K 0.15%
3,000
– –
2 3
4
5 6

Similar funds

OCM
Ogborne Capital Management San Francisco, California $287M AUM 14.05% 1-Year Est. Return
RSC
Red Spruce Capital Berwyn, Pennsylvania $287M AUM 38.81% 1-Year Est. Return
MC
Metavasi Capital Larchmont, New York $287M AUM 97.9% 1-Year Est. Return
QFW
QTR Family Wealth Lake Mary, Florida $287M AUM 40.55% 1-Year Est. Return
SRWM
Shira Ridge Wealth Management Larkspur, California $287M AUM 23.34% 1-Year Est. Return
ORC
O'Rourke & Company Boston, Massachusetts $287M AUM 23.01% 1-Year Est. Return
MPAM
Murphy Pohlad Asset Management Eden Prairie, Minnesota $287M AUM 38.81% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return

Pavaki Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Pavaki Capital Management held 162 positions worth $235M, down 7.8% from $255M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Pavaki Capital Management deployed $10.3M of net new capital in Q1 2026, opening 31 new positions and adding to 16 existing holdings. Its largest new stake was iShares MSCI Singapore ETF: 60,000 shares worth $1.69M.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $8.8M trimmed.

  • Pavaki Capital Management's largest Q1 2026 buy was iShares MSCI Singapore ETF: 60,000 shares worth $1.69M.
  • Pavaki Capital Management added most to Chevron in Q1 2026, an estimated $13.2M increase.
  • Pavaki Capital Management's biggest Q1 2026 reduction was Regeneron Pharmaceuticals, cutting an estimated $8.8M.
  • Pavaki Capital Management fully exited Roivant Sciences in Q1 2026, selling an estimated $868K.
  • Pavaki Capital Management's ten largest holdings make up 50% of its $235M portfolio in Q1 2026.
  • Pavaki Capital Management opened 31 new positions and closed 6 in Q1 2026.
  • Pavaki Capital Management's portfolio value fell 7.8% quarter-over-quarter to $235M.

Based on Pavaki Capital Management's 13F filing for Q1 2026, filed 7 Aug 2026.